Approved Treatments

Acthar Gel is a repository corticotropin injection approved for the treatment of several conditions, including pulmonary sarcoidosis. Acthar Gel is administered as an injection under the skin (subcutaneously) or into the muscle tissue (intramuscularly). It is an alternative treatment for patients who do not tolerate or respond to the corticosteroid prednisone, which is the first-line treatment for sarcoidosis.

Prednisone is a corticosteroid approved to treat many different conditions and has proven effective in treating the symptoms of sarcoidosis. It works by mimicking the effect of cortisol, a naturally-occurring steroid hormone in the body, making the immune system less sensitive to what it perceives as threats.